Editor's Note The Centers for Disease Control and Prevention (CDC) on September 15 reported that 121 of nearly 392,000 children and young adults who contracted COVID-19 in the US have died. Three-quarters of the deaths involved at least one comorbidity and 45% had two or more, with the most common…

Read More

Editor's Note Masks, such as N95 respirators, are made of material with sufficient high filter capacity to protect against airborne respiratory viruses. However, viral protection can only be provided by masks that properly fit the wearer’s face and provide a tight facial seal, this review article finds. Among the findings:…

Read More

Editor's Note ECRI and the Institute for Safe Medication Practices (ISMP) are joining global leaders in celebrating World Patient Safety Day, September 17, 2020. This year’s theme is “Health Worker Safety: A Priority for Patient Safety.” In honor of the day and to support healthcare workers, ECRI has launched a…

Read More

Editor's Note Dozens of nursing homes and hospitals ignored official guidelines from the Centers for Disease Control and Prevention (CDC) to separate COVID-19 patients from those without the virus, the September 10 Kaiser Health News reports. A Kaiser Health News investigation found that nursing homes and hospitals ignored (CDC) guidelines…

Read More

Editor's Note Washington University School of Medicine in St Louis is the clinical coordinating center for a new worldwide clinical trial to test whether the vaccine for measles, mumps, and rubella (MMR) can protect frontline healthcare workers (HCWs) against COVID-19. The researchers say there are two main reasons why the…

Read More

Editor's Note In this international meta-analysis, researchers found that the administration of systemic corticosteroids was associated with lower 28-day all-cause mortality in critically ill COVID-19 patients. The meta-analysis included seven randomized studies from 12 countries that involved 1,703 critically ill COVID-19 patients. Patients had been randomized to receive systemic dexamethasone,…

Read More

Editor's Note In this study from Russia’s Gamaleya National Research Center for Epidemiology and Microbiology, researchers found that a heterologous COVID-19 vaccine based on recombinant human adenovirus type 26 (rAD26) and type 5 (rAD5) had a good safety profile over 42 days and induced strong antibody responses in all participants…

Read More

Editor's Note This study led by researchers at the Boston University School of Public Health finds that depression symptoms in the US are three-fold higher than they were before the COVID-19 pandemic. Of 1,441 individuals surveyed during the COVID-19 pandemic and 5,065 surveyed before the pandemic, depression symptoms were higher…

Read More

Editor's Note In an August 27 letter, Robert Redfield, MD, director of the Centers for Disease Control and Prevention (CDC), asked the nation’s governors to have COVID-19 vaccine distribution sites fully operational by November 1, the September 2 McClatchy DC reports. Delivery firms received guidance to prepare freezer farms in…

Read More

Editor's Note This prospective meta-analysis from the World Health Organization (WHO) Rapid Evidence Appraisal for COVID-19 Therapies, which pooled data from seven randomized clinical trials of critically ill patients with COVID-19, finds that administration of systemic corticosteroids, compared with usual care or placebo, was associated with lower 28-day all-cause mortality.…

Read More